A Study to Investigate the Effect of CYP3A Inhibition on the Pharmacokinetics of RG1662 in Healthy Subjects

NCT02470832 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Patient Study

Interventions

DRUG: RG1662
DRUG: itraconazole

Sponsor

Hoffmann-La Roche